ArticleAmerican journal of medical genetics. Part A2017

Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I.

Igor Nestrasil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.